GLB-2001

N/A

Report date: 2025/07/03 16:42:38

Base Information

Drug NameGLB-2001
Drug Alias NameAAV-8-pXLLY-027GLB-2001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transferenceCoagulation factor IX modulators
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeneLeap Biotechnology LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeneLeap Biotechnology LLC
Active IndicationsN/A
Inactive IndicationsHemophilia B

Other Information

ATC CodeN/A
Related LinksN/A